Enhanced Recovery and Opioid-Sparing Pain Management Following Lung Transplantation

Adequate pain control is essential following lung transplantation to reduce patient stress and minimize perioperative complications. Enhanced recovery after surgery (ERAS) protocols have demonstrated improvements in patient experience and reduced length of stay. However, the implementation of these protocols has not yet extended to the lung transplant population.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: (209) Source Type: research

Related Links:

AbstractAimTo provide a multidimensional assessment of self ‐reported chronic pain 1–5 years after heart transplantation and its relationship with self‐reported well‐being, fatigue, recovery, self‐efficacy and socio‐economic factors and to explore differences between heart recipients and a cohort of lung recipients.DesignThis multicentre, cross ‐sectional, cohort study is a part of the Swedish national Self‐management after thoracic transplantation study.MethodsSix questionnaires were distributed at the heart recipients yearly follow ‐up (1–5 years) at three Swedish university hospital...
Source: Nursing Open - Category: Nursing Authors: Tags: RESEARCH ARTICLE Source Type: research
We describe the anesthetic management for this innovative technique addressing technique-specific issues such as arrhythmia management, hemostasis, right heart failure and postoperative pain control.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: (852) Source Type: research
Abstract Sickle cell disease afflicts millions of people worldwide and approximately 100,000 Americans. Complications are myriad and arise as a result of complex pathological pathways 'downstream' to a point mutation in DNA, and include red blood cell membrane damage, inflammation, chronic hemolytic anemia with episodic vaso-occlusion, ischemia and pain, and ultimately risk of cumulative organ damage with reduced patient lifespan. The National Heart, Lung, and Blood Institute's 2014 evidence-based guideline for sickle cell disease -management states additional research is needed before investigational curative the...
Source: Haematologica - Category: Hematology Authors: Tags: Haematologica Source Type: research
Discussion Transplantation is not a common problem for primary care physicians but when a child’s disease has progressed to end-stage organ failure, transplantation can be the only treatment available. While the primary care provider usually is not involved in the daily management of patients before, during and after transplantation, they can be involved in many areas. These can include providing appropriate primary and acute care, ordering and obtaining necessary medical tests, medications and equipment, assisting with medical insurance, providing medical history and records to consultants, translating medical infor...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
Ryan R. Kelly1,2†, Lindsay T. McDonald1,2†, Nathaniel R. Jensen1,2, Sara J. Sidles1,2 and Amanda C. LaRue1,2* 1Research Services, Ralph H. Johnson VA Medical Center, Charleston, SC, United States 2Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States The significant biochemical and physiological effects of psychological stress are beginning to be recognized as exacerbating common diseases, including osteoporosis. This review discusses the current evidence for psychological stress-associated mental health disorders as risk factors for os...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Less invasive techniques for left ventricular assist device (LVAD) implantation have shown promising outcomes but are associated with significant postoperative pain. We aimed to investigate the use of ultrasound-guided regional nerve blocks to improve pain management during these procedures.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 935 Source Type: research
Patients undergoing heart lung / lung transplantation utilise extensive hospital resources. Pain management is an important factor in post surgery recovery, influencing respiratory and other health outcomes and hospital resource burden. To our knowledge, no previous study has evaluated analgesic practices in the paediatric heart lung / lung transplant population.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 1199 Source Type: research
Publication date: Available online 6 September 2018Source: Anaesthesia &Intensive Care MedicineAuthor(s): Mark Buckland, Bronwyn Scarr, Chris DurkinAbstractHeart and lung transplantation rates continue to rise with median survival rates of 11 and 7.4 years, respectively, with transplantation becoming the definitive therapy for end-stage disease of each system. Indications for lung transplantation are categorized as suppurative, obstructive, restrictive and pulmonary vascular. Surgical options include single lung, bilateral sequential single lung and heart–lung transplantation. Each has their own intraoperative ch...
Source: Anaesthesia and intensive care medicine - Category: Anesthesiology Source Type: research
The FDA today granted pre-market approval under its breakthrough devices designation to the Zephyr endobronchial valve made by Pulmonx for treating severe emphysema. Emphysema, a chronic obstructive pulmonary disease, causes irreversible damage to the lung’s alveoli, trapping air during exhalation that in turn can cause the diseased tissue to grow larger and pressure healthy lung tissue. The Zephyr device is designed to decrease the volume of the chest to improve function in the heart, respiratory muscles and healthy lung tissue. Inserted via bronchoscopy, the pencil-eraser-sized valves prevent air from ent...
Source: Mass Device - Category: Medical Devices Authors: Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Pulmonx Source Type: news
More News: Cardiology | Heart | Heart Transplant | Lung Transplant | Pain | Pain Management | Transplant Surgery | Transplants